Speech Therapy Frequency for Pediatric Speech and Language Disorders
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to compare speech therapy outcomes in children ages 18 months to 16 years who participate in weekly speech therapy with home programming versus every-other week speech therapy with home programming in outpatient speech therapy. The main question it aims to answer is: Does a change in how often speech therapy sessions are delivered show an increased benefit in language and articulation standardized test scores? Participants will be randomly assigned to either (1) weekly or (2) every-other-week speech therapy for a total of 8 sessions. Researchers will compare these two groups to see if there are differences in speech outcomes.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It seems focused on speech therapy frequency, so it's unlikely that medication changes are required.
What data supports the effectiveness of the treatment Speech Therapy for Pediatric Speech and Language Disorders?
Research shows that children receiving speech therapy in schools improved their speech sound accuracy, with gains linked to the number of therapy sessions. Parents and therapists were generally satisfied with the outcomes, and children with mild speech sound disorders benefited from frequent, short individual sessions.12345
Is speech therapy safe for children with speech and language disorders?
How does the treatment 'Speech Therapy' differ from other treatments for pediatric speech and language disorders?
Speech Therapy for pediatric speech and language disorders is unique because it focuses on the frequency and intensity of sessions, with recent research suggesting that spaced, low-frequency but highly productive sessions can be more beneficial than more frequent sessions. This approach contrasts with traditional methods that often emphasize more frequent sessions, highlighting the importance of tailoring therapy to individual needs and optimizing the 'dose' of therapy for better outcomes.1671011
Research Team
Jodi Urzua, MS
Principal Investigator
Connecticut Children's Medical Center
Virginia Van Epps, M.Ed.
Principal Investigator
Connecticut Children's Medical Center
Mary Dortenzio, MS
Principal Investigator
Connecticut Children's Medical Center
Emma Mendillo, MA
Principal Investigator
Connecticut Children's Medical Center
Morgan Daur-Schierholz, MS
Principal Investigator
Connecticut Children's Medical Center
Eligibility Criteria
This trial is for children aged 18 months to 16 years who need speech therapy and have completed one plan of care. They must attend at least 80% of their sessions, be recommended for individual treatment, and have a diagnosis related to language or articulation disorders. It's not for those unable to complete certain standardized tests or seeking therapy for voice, feeding, fluency, cognition issues.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either weekly or every-other-week speech therapy with home programming for a total of 8 sessions
Follow-up
Participants are monitored for changes in vocabulary and articulation skills after treatment
Treatment Details
Interventions
- Speech Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Connecticut Children's Medical Center
Lead Sponsor